Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient.
Annals of hematology
View this publicationAnnals of hematology
View this publicationScience (New York, N.Y.)
View this publicationEpigenomics
View this publicationCell reports
View this publicationProceedings of the National Academy of Sciences of the United States of America
View this publicationTranslational psychiatry
View this publicationTranslational psychiatry
View this publicationFrontiers in immunology
View this publicationTransplant international : official journal of the European Society for Organ Transplantation
View this publicationGenes
View this publication